Table 1

Baseline Characteristics of the Study Population

Total (n = 127)DES (n = 71)BMS (n = 56)p Value
Age, yrs69.9 ± 8.868.8 ± 8.670.2 ± 7.60.61
Male gender, n (%)110 (86.6)61 (85.9)49 (87.5)1.0
Hypertension, n (%)85 (66.9)50 (70.4)35 (62.5)0.45
Diabetes, n (%)30 (24.0)16 (22.5)14 (25)0.83
 Noninsulin-dependent diabetes, n (%)26 (86.7)12 (75.0)14 (100.0)
 Insulin-dependent diabetes, n (%)4 (13.3)4 (25.0)0 (0.0)
Hyperlipidemia, n (%)59 (46.4)38 (53.5)21 (37.5)0.05
Current smoker, n (%)8 (6.3)6 (8.5)2 (3.6)0.46
Family history of CAD, n (%)45 (35.4)23 (32.4)22 (39.3)0.46
Previous MI, n (%)68 (53.5)38 (53.5)30 (53.6)1.0
Previous PCI, n (%)48 (37.8)28 (39.4)20 (35.7)0.71
Previous CABG, n (%)39 (30.7)23 (32.4)16 (28.6)0.70
LVEF, %44.9 ± 13.244.6 ± 12.747.4 ± 15.50.24
Stable angina, n (%)60 (47.2)34 (47.9)26 (46.4)0.04
Unstable angina, n (%)29 (22.8)11 (15.5)18 (32.1)0.04
STEMI, n (%)4 (3.1)1 (1.4)3 (5.4)0.32
CHADS2 risk score for AF patients1.79 ± 1.231.96 ± 1.211.59 ± 1.210.32

AF = atrial fibrillation; BMS = bare-metal stents; CABG = coronary artery bypass grafting; CAD = coronary artery disease; CHADS2 = Congestive heart failure, Hypertension, Age >75 years, Diabetes, prior transient ischemic attack, or Stroke-2; DES = drug-eluting stents; LVEF = left ventricular ejection fraction; MI = myocardial infarction; PCI = percutaneous coronary intervention; STEMI = ST-segment elevation myocardial infarction.